Latest News & Features
Americas
The number of potentially anticompetitive patent infringement settlements between brand drugmakers and generic competitors remained low in 2017, according to the Federal Trade Commission. 7 December 2020
Americas
Pharmaceutical companies Illumina and Roche have been sued for allegedly infringing two patents covering the technology for non-invasive DNA testing by Maryland genetic testing company Ravgen. 7 December 2020
Americas
Abbott Laboratories must face allegations brought by Grifols Diagnostic and a Novartis subsidiary that its HIV testing products infringe a patent covering a method to create HIV proteins using recombinant DNA. 4 December 2020
Generics
Amgen and Teva will have to face a lawsuit accusing them of restricting competition by engineering a reverse payment designed to keep generic versions of Sensipar off the market. 3 December 2020
Americas
Teva has urged the US Court of Appeals for the Federal Circuit to rehear its dispute with GlaxoSmithKline en banc, claiming that if the decision is upheld, “every skinny-labelled generic is at risk”. 3 December 2020
Americas
A medical technology subsidiary of Siemens has settled a lawsuit against a former vice president, who it accused of stealing trade secrets related to heart catheter devices. 3 December 2020
Americas
The US Immigration and Customs Enforcement has unveiled the next stage of its operation to combat a wave of fraudulent vaccines and treatments, after seizing more than $26 million in illicit proceeds from COVID-19 related products over the past six months. 2 December 2020
Biotechnology
The UK Competition and Markets Authority is investigating Essential Pharma over suspicions that the pharmaceutical company contravened competition law by proposing to withdraw the supply of Priadel, a lithium-based medication for bipolar disease. 30 November 2020
Asia-Pacific
The Federal Court of Australia has granted Pfizer subsidiary Wyeth’s bid for an injunction against Merck Sharp Dohme in a dispute over vaccine patents. 30 November 2020
Europe
Médecins Sans Frontières has warned that the European Commission’s commitment to the supplementary protection certificate system risks undermining its promise to improve drug accessibility. 30 November 2020